Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 9,704 shares at $82.09 ($808K) on 2015-09-25, disclosed to the SEC on 2015-09-28.
Scheduled sale ($808k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.42 | 2,426 | $205K | 25.4% |
| 2 | $84.43 | 2,426 | $205K | 25.4% |
| 3 | $82.07 | 2,426 | $199K | 24.6% |
| 4 | $82.09 | 2,426 | $199K | 24.7% |
| Total | $83.25 avg | 9,704 | $808K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |